Cargando…
Inhibition of archaeal growth and DNA topoisomerase VI activities by the Hsp90 inhibitor radicicol
Type II DNA topoisomerases have been classified into two families, Topo IIA and Topo IIB, based on structural and mechanistic dissimilarities. Topo IIA is the target of many important antibiotics and antitumoural drugs, most of them being inactive on Topo IIB. The effects and mode of action of Topo...
Autores principales: | Gadelle, D., Bocs, C., Graille, M., Forterre, P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1084324/ https://www.ncbi.nlm.nih.gov/pubmed/15849317 http://dx.doi.org/10.1093/nar/gki526 |
Ejemplares similares
-
Structural basis for topoisomerase VI inhibition by the anti-Hsp90 drug radicicol
por: Corbett, Kevin D., et al.
Publicado: (2006) -
Understanding the Hsp90 N-Terminal Dynamics: Structural and Molecular Insights into the Therapeutic Activities of Anticancer Inhibitors Radicicol (RD) and Radicicol Derivative (NVP-YUA922)
por: Magwenyane, Ayanda M., et al.
Publicado: (2020) -
Phylogenomics of DNA topoisomerases: their origin and putative roles in the emergence of modern organisms
por: Forterre, Patrick, et al.
Publicado: (2009) -
Expanding the type IIB DNA topoisomerase family: identification of new topoisomerase and topoisomerase-like proteins in mobile genetic elements
por: Takahashi, Diane T, et al.
Publicado: (2019) -
DNA topoisomerase VIII: a novel subfamily of type IIB topoisomerases encoded by free or integrated plasmids in Archaea and Bacteria
por: Gadelle, Danièle, et al.
Publicado: (2014)